Milton Johnson, who retired as the company’s CEO at the end of last year, was paid $21.4 million in 2018, nearly $4.2 million more than he earned in 2017, according to a recent Securities and Exchange Commission filing.
Several other members of HCA’s C-suite also received pay raises last year. Samuel Hazen, who served as president and COO before taking over as CEO Jan. 1, saw his total pay climb from $9.5 million in 2017 to $10 million in 2018. HCA Executive Vice President and CFO William Rutherford earned $6.8 million last year, up from $4.9 million in 2017.
The executives’ compensation increased as HCA’s bottom line grew. The company ended 2018 with a $3.8 billion profit on revenue of $46.7 billion. In 2017, HCA reported a profit of $2.2 billion on revenue of $43.6 billion.
More articles on healthcare finance:
Freestanding EDs charge up to 22 times more than physician offices, UnitedHealth study finds
Indiana hospital closure will result in 269 layoffs
Pennsylvania hospital shortchanges workers’ paychecks — again
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
